English | Español

Technology/Innovation
+ Technology/Innovation
Patient Daily Report | May 11, 2023

New Medical Device Offers Solution for Abnormal Uterine Bleeding
+ Community
Sam Jackson | May 10, 2023

Scottsdale doctor on sinusitis: 'If quality of life is not optimized, it's our job as physicians to help patients navigate through those challenges'
+ Technology/Innovation
Patient Daily Report | May 10, 2023

Medtronic receives approval for new automated insulin pump that offers insulin corrections in real time
+ Community
Patient Daily | May 9, 2023

Lilly Provides $500,000 in Grants to Support Equitable Access to Education for Dreamers in Indiana
+ Regulatory
Patient Daily | May 9, 2023

Lilly Declares Second-Quarter 2023 Dividend
+ Technology/Innovation
Patient Daily | May 9, 2023

Lilly's tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes in SURMOUNT-2
+ Community
Patient Daily Report | May 9, 2023

Samet: 'I think that smoking will continue to ebb downwards'
+ Technology/Innovation
Mifeed | May 8, 2023

Cell Manufacturing Pioneer, Pluri Inc., Unveils PluriMatrix: a Breakthrough System for Unprecedented Industrial Scale Production of Cell-Based Products

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation